The recent history of neural transplantation using the adrenal medulla
parallels an evolution in our thinking about neural grafting as a the
rapeutic approach to treat neurodegenerative diseases such as Parkinso
n's disease. Initially, neural grafting was an approach to study devel
opment and regeneration. With the discovery that adrenal chromaffin ce
ll grafts would ameliorate some of the motor deficits associated with
the loss of striatal dopamine, adrenal grafts were used to provide dop
amine to the dopamine-depleted striatum. However, subsequent studies s
howed poor chromaffin cell survival unless trophic factors were presen
t at the site of transplantation. These experiments lead to the apprec
iation of the complex interactions between neurotrophic factors, infla
mmatory cytokines, the grafted tissue, and the host brain's response.
Thus, we find ourselves again using neural transplantation as an appro
ach to help us better understand central nervous system plasticity and
the features this plasticity shares in common with development and re
generation. (C) 1994 Wiley-Liss, Inc.